Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer

The objective of this study is to examine how adenocarcinoma of the prostate treatment
differentially affects African American men's ability to work and to describe and compare
changes in work ability (as measured through self-reported global work ability item) reported
by African American and white adenocarcinoma of the prostate survivors before treatment and 6
months after treatment completion.

Intervention

Interview, Questionnaire Administration

Condition

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer

Investigators

Joanne Sandberg, Priyank P. Patel, Scott E. Delacroix, Gregory A. Masters, Bryan A. Faller, William P. Fusselman, Robert J. Isaak, Richard L. Deming, Robert J. Behrens, David S. Hanson, Kathleen J. Yost, Pamala A. Pawloski, Jay W. Carlson, Jayadev Manikkam Umakanthan, Preston D. Steen, Timothy D. Moore, Chanita Hughes-Halbert, Jeffrey K. Giguere, Michael Humeniuk, Robert D. Siegel, Dean A. Delmastro, Gary L. Buchschacher, William J. Irvin, Thomas E. Lad, Bart A. Frizzell, Riccardo Autorino, Stephen J. Ramey

See list of participating sites